Johnson DH - Search Results

1

Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.

Pisters KM, Kris MG, Bunn PA Jr, Johnson DH, Ruckdeschel JC, Crowley JJ, Ginsberg RJ. Pisters KM, et al. Among authors: johnson dh. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-41-S12-44. Semin Oncol. 1997. PMID: 9331120

2

Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.

Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB Jr, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ, Bunn PA Jr. Pisters KM, et al. Among authors: johnson dh. J Thorac Cardiovasc Surg. 2000 Mar;119(3):429-39. doi: 10.1016/s0022-5223(00)70120-6. J Thorac Cardiovasc Surg. 2000. PMID: 10694600 Clinical Trial.

3

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.

Wolff AC, Ettinger DS, Neuberg D, Comis RL, Ruckdeschel JC, Bonomi PD, Johnson DH. Wolff AC, et al. Among authors: johnson dh. J Clin Oncol. 1995 Jul;13(7):1615-22. doi: 10.1200/JCO.1995.13.7.1615. J Clin Oncol. 1995. PMID: 7602350 Clinical Trial.

4

Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.

DeVore RF 3rd, Jagasia M, Johnson DH. DeVore RF 3rd, et al. Among authors: johnson dh. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-27-S12-29. Semin Oncol. 1997. PMID: 9331116 Clinical Trial.

5

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer.

Johnson DH, Ruckdeschel JC, Keller JH, Lyman GH, Kallas GJ, Macdonald J, DeConti RC, Lee J, Ringenberg QS, Patterson WP, et al. Johnson DH, et al. Cancer. 1991 Jan 1;67(1 Suppl):245-9. doi: 10.1002/1097-0142(19910101)67:1+<245::aid-cncr2820671306>3.0.co;2-z. Cancer. 1991. PMID: 1845847 Clinical Trial.

6

Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.

Choy H, DeVore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH. Choy H, et al. Among authors: johnson dh. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-21-S12-26. Semin Oncol. 1997. PMID: 9331115 Clinical Trial.

7

Paclitaxel plus carboplatin for advanced lung cancer: preliminary results of a Vanderbilt University phase II trial--LUN-46.

Johnson DH, Paul DM, Hande KR, DeVore RF 3rd. Johnson DH, et al. Semin Oncol. 1995 Aug;22(4 Suppl 9):30-3. Semin Oncol. 1995. PMID: 7644925 Clinical Trial.

8

Chemotherapy for unresectable non-small cell lung cancer.

Johnson DH. Johnson DH. Semin Oncol. 1990 Aug;17(4 Suppl 7):20-9. Semin Oncol. 1990. PMID: 2166346 Review.

9

Chemotherapy of small-cell lung cancer.

Greco FA, Johnson DH, Hainsworth JD, Wolff SN. Greco FA, et al. Among authors: johnson dh. Semin Oncol. 1985 Dec;12(4 Suppl 6):31-7. Semin Oncol. 1985. PMID: 3001942 Review.

10

Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).

Johnson DH, Paul DM, Hande KR, DeVore R. Johnson DH, et al. Semin Oncol. 1996 Dec;23(6 Suppl 16):42-6. Semin Oncol. 1996. PMID: 9007120 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters